hcv medication, liver, plump dj , vitamin e, treatment, seroprevalence, hcv virus, cirrhosis, ldl cholesterol, infection, combination therapy, information, big fat girls , ncbi, plump video , bobby plump , nonalcoholic fatty liver diseasee treatments, sexy plump women , omega3 fatty acids , plump gallery , plump asian , chronic liver inflammation, peglation, cholangiocarcinoma,
|
21 No. 4 472-475 1. Dr. Sh. Ravanshad PhD 2. Mr. plump ladies B. Amirkalali M.Sc. 3. Dr. M. Saberfirozi MD 4. Dr. N. Zare PhD 5. Dr. E. Setoudeh Maram PhD 1,2. Department of Nutrition School of Public Health 3. Department of Internal Medicine School of Medicine 4,5. Department of Epidemiology & Biostatistics School of Public Health 1-5: Shiraz Univesity of Medical Sciences Shiraz, IRAN Correspondence: Dr. Sh. Ravanshad P.O. Box: 71345 / 1711, Shiraz, IRAN E-mail: setodeha@sums.ac.ir Received for publication: April plump ladies 13, 2005 Accepted: June 28, 2005 Introduction plump ladies Non-Alcoholic Fatty Liver Disease (NAFLD) is becoming the preferred term, and it refers to a wide spectrum of liver damage, ranging from simple steatosis to steato-hepatitis, advanced fibrosis and cirrhosis. NAFLD affects 10 to 24% of general population in various countries. The prevalence increases to 57.5%1 to 74%2,3 in obese persons. Non-Alcoholic Fatty Liver Disease affects 2.6% of children4 and 22.5%4
|